1. |
Mautner VF, Asuagbor FA, Dombi E, et al. Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1. Neuro Oncology, 2008, 10(4): 593-598.
|
2. |
Waggoner DJ, Towbin J, Gottesman G, et al. Clinic-based study of plexiform neurofibromas in neurofibromatosis 1. Am J Med Genet, 2000, 92(2): 132-135.
|
3. |
Gross AM, Wolters PL, Dombi E, et al. Selumetinib in children with inoperable plexiform neurofibromas. N Engl J Med, 2020, 382(15): 1430-1442.
|
4. |
Voelker R. A new treatment for children with neurofibromatosis type 1. JAMA. 2020, 323(19): 1887. doi: 10.1001/jama.2020.7157.
|
5. |
Fisher JM, Blakeley JO, Weiss BD, et al. Management of neurofibromatosis type 1-associated plexiform neurofibromas. Neuro Oncology, 2022, 24(11): 1827-1844.
|
6. |
王智超, 李青峰. Ⅰ型神经纤维瘤病临床诊疗专家共识 (2021 版). 中国修复重建外科杂志, 2021, 35(11): 1384-1395.
|
7. |
Bashiri FA, Hundallah K, Abukhaled M, et al. Diagnosis and management of neurofibromatosis type 1 in Arabian Gulf Cooperation Council Region: challenges and recommendations. Front Oncol, 2024, 14: 1323176. doi: 10.3389/fonc.2024.1323176.
|
8. |
Armstrong AE, Belzberg AJ, Crawford JR, et al. Treatment decisions and the use of MEK inhibitors for children with neurofibromatosis type 1-related plexiform neurofibromas. BMC Cancer, 2023, 23(1): 553. doi: 10.1186/s12885-023-10996-y.
|
9. |
梁汉生, 冯艺. 术中神经电生理监测的现状及展望. 中华医学杂志, 2015, 95(21): 1646-1647.
|
10. |
Garozzo D. Peripheral nerve tumors in neurofibromatosis 1: An overview on management and indications for surgical treatment in our experience. Neurol India, 2019, 67(Supplement): S38-S44.
|
11. |
Zelenski NA, Oishi T, Shin AY. Intraoperative neuromonitoring for peripheral nerve surgery. J Hand Surg (Am), 2023, 48(4): 396-401.
|
12. |
Rich BS, Brown EG, Rothstein DH, et al. The utility of intraoperative neuromonitoring in pediatric surgical oncology. J Pediatr Surg, 2023, 58(9): 1708-1714.
|
13. |
Nelson CN, Dombi E, Rosenblum JS, et al. Safe marginal resection of atypical neurofibromas in neurofibromatosis type 1. J Neurosurg, 2019, 133(5): 1516-1526.
|
14. |
Rijken BF, Veelen-Vincent ML, Mathijssen IM. Sphenoid dysplasia in patients with neurofibromatosis type 1: Clinical features and imaging findings including cerebrospinal fluid alterations. Eur J Paediatr Neurol, 2023, 42: 28-33.
|
15. |
Anetakis KM, Dolia JN, Desai SM, et al. Last electrically well: intraoperative neurophysiological monitoring for identification and triage of large vessel occlusions. J Stroke Cerebrovasc Dis, 2020, 29(10): 105158. doi: 10.1016/j.jstrokecerebrovasdis.2020.105158.
|
16. |
Matsuo R, Kamouchi M, Inoue T, et al. Cerebral infarction due to carotid occlusion caused by cervical vagal neurilemmoma: report of a case. Stroke, 2002, 33(5): 1428-1431.
|